Estimating the long-term costs of diabetic kidney disease: an economic approach

Mark Knezevic

Applied Economics Letters, 2009, vol. 16, issue 10, pages 1059-1064

Abstract: Healthcare spending in Australia has increased rapidly in recent decades, partly due to the prevalence of lifestyle related illness, as physical inactivity and ageing have become common. Diabetes is a chronic and costly illness resulting from poor lifestyle choice and ageing. In this study, we estimate the long-run cumulative costs of a complication of diabetes, diabetic kidney disease, using well-known techniques from health economics. We find that spending on treatment for diabetic kidney disease will amount to $9.2 billion over the next 30 years. Most of the cost from this complication comes from the clinical stage of diabetic kidney disease.

Date: 2009

Downloads: (external link)
http://www.informaworld.com/openurl?genre=article& ... 40C6AD35DC6213A474B5 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:taf:apeclt:v:16:y:2009:i:10:p:1059-1064

Ordering information: This journal article can be ordered from
http://www.tandf.co.uk/journals/subscription.html

Access Statistics for this article

Applied Economics Letters is edited by Mark Taylor

More articles in Applied Economics Letters from Taylor and Francis Journals
Series data maintained by Christopher F. Baum ().